Beyond expectations: disease duration and psychological burden in psoriatic arthritis
View/ Open
Access
info:eu-repo/semantics/closedAccessDate
2023Author
Kılıç, GamzeKılıç, Erkan
Tekeoğlu, İbrahim
Sargın, Betül
Cengiz, Gizem
Balta, Nihan Cüzdan
Alkan, Hakan
Kasman, Sevtap Acer
Şahin, Nilay
Orhan, Kevser
Gezer, İlknur Albayrak
Keskin, Dilek
Mülkoğlu, Cevriye
Resorlu, Hatice
Ataman, Şebnem
Bal, Ajda
Duruöz, Mehmet Tuncay
Küçükakkaş, Okan
Şen, Nesrin
Toprak, Murat
Yurdakul, Ozan Volkan
Melikoğlu, Meltem Alkan
Ayhan, Fikriye Figen
Baykul, Merve
Bodur, Hatice
Çalış, Mustafa
Çapkın, Erhan
Devrimsel, Gül
Hizmetli, Sami
Kamanlı, Ayhan
Keskin, Yaşar
Ecesoy, Hilal
Kutluk, Öznur
Şendur, Ömer Faruk
Tolu, Sena
Tuncer, Tiraje
Nas, Kemal
Metadata
Show full item recordCitation
Kılıç, G., Kılıç, E., Tekeoğlu, İ., Sargın, B., Cengiz, G., Balta, N. C., Alkan, H., Kasman, S. A., Şahin, N., Orhan, K., Gezer, İ. A., Keskin, D., Mülkoğlu, C., Reşorlu, H., Ataman, Ş., Bal, A., Duruöz, M. T., Küçükakkaş, O., Şen, N., Toprak, M., … Nas, K. (2023). Beyond expectations: disease duration and psychological burden in psoriatic arthritis. Rheumatology international, 43(9), 1695–1704. https://doi.org/10.1007/s00296-023-05379-2Abstract
This study aims to investigate the relationship between disease duration and psychological burden in PsA and to identify the risk factors associated with psychological distress. Patients with PsA who met CASPAR classification criteria enrolled by Turkish League Against Rheumatism (TLAR)-Network. Patients were categorized into three groups based on disease duration: early stage (< 5 years), middle stage (& GE; 5, < 10 years), and late stage (& GE; 10 years). All patients underwent clinical and laboratory assessment using standardized protocol and case report forms. The associations between psychological variables and clinical parameters were assessed by a multivariate analysis. Of the 1113 patients with PsA (63.9% female), 564 (%50.7) had high risk for depression and 263 (%23.6) for anxiety. The risk of psychological burden was similar across all PsA groups, and patients with a higher risk of depression and anxiety also experienced greater disease activity, poorer quality of life, and physical disability. Multivariate logistic regression revealed that female gender (OR = 1.52), PsAQoL (OR = 1.13), HAQ (OR = 1.99), FiRST score (OR = 1.14), unemployment/retired (OR = 1.48) and PASI head score (OR = 1.41) were factors that influenced the risk of depression, whereas the current or past enthesitis (OR = 1.45), PsAQoL (OR = 1.19), and FiRST score (OR = 1.26) were factors that influenced the risk of anxiety. PsA patients can experience a comparable level of psychological burden throughout the course of their disease. Several socio-demographic and disease-related factors may contribute to mental disorders in PsA. In the present era of personalized treatment for PsA, evaluating psychiatric distress can guide tailored interventions that improve overall well-being and reduce disease burden.